{"id":"NCT02207088","sponsor":"AbbVie","briefTitle":"Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease","officialTitle":"An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-23","primaryCompletion":"2016-12-06","completion":"2016-12-06","firstPosted":"2014-08-01","resultsPosted":"2017-11-09","lastUpdate":"2017-11-09"},"enrollment":68,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C","Hepatitis C Virus","Compensated Cirrhosis","Severe Renal Impairment","End-stage Renal Disease"],"interventions":[{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir","otherNames":["ABT-450/r/ABT-267","Viekira Pak","paritaprevir also known as ABT-450","ombitasvir also known as ABT-267","dasabuvir also known as ABT-333"]},{"type":"DRUG","name":"dasabuvir","otherNames":["ABT-333"]},{"type":"DRUG","name":"Ribavirin","otherNames":["RBV"]}],"arms":[{"label":"3-DAA (Direct Acting Antivirals) with or without RBV","type":"EXPERIMENTAL"}],"summary":"This open-label study will evaluate safety, pharmacokinetics and efficacy of a 12 or 24-week regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin in HCV-genotype 1-infected subjects with an Estimated Glomerular Filtration Rate (eGFR) \\<30, including those on hemodialysis or peritoneal dialysis.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 (SVR12) Weeks Post-treatment","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"3-DAA Â± RBV","deltaMin":94.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30291369","26976799"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":68},"commonTop":["ANAEMIA","FATIGUE","DIARRHOEA","NAUSEA","VOMITING"]}}